These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 12223069)

  • 1. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of costimulation to enhance tumor immunity.
    Vesosky B; Hurwitz AA
    Cancer Immunol Immunother; 2003 Nov; 52(11):663-9. PubMed ID: 12920481
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
    Vanhove B; Laflamme G; Coulon F; Mougin M; Vusio P; Haspot F; Tiollier J; Soulillou JP
    Blood; 2003 Jul; 102(2):564-70. PubMed ID: 12649149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding world of co-stimulation: the two-signal model revisited.
    Chambers CA
    Trends Immunol; 2001 Apr; 22(4):217-23. PubMed ID: 11274928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B; Bluestone JA
    Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM; Collins M
    Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4Ig: uses and future directions.
    Ben-Shoshan M
    Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):132-42. PubMed ID: 19519590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
    Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
    Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA
    Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
    Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
    J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation requirements of induced murine systemic autoimmune disease.
    Pollard KM; Arnush M; Hultman P; Kono DH
    J Immunol; 2004 Nov; 173(9):5880-7. PubMed ID: 15494542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B7 family revisited.
    Greenwald RJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
    Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
    Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28-independent induction of experimental autoimmune encephalomyelitis.
    Chitnis T; Najafian N; Abdallah KA; Dong V; Yagita H; Sayegh MH; Khoury SJ
    J Clin Invest; 2001 Mar; 107(5):575-83. PubMed ID: 11238558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
    Popma SH; Krasinskas AM; Kreisel D; Szeto W; McLean AD; Moore JS; Rosengard BR
    Transplant Proc; 2001; 33(1-2):767-9. PubMed ID: 11267061
    [No Abstract]   [Full Text] [Related]  

  • 20. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.